CRP and melanoma: Other circulating proteins such as S100β, C-reactive protein (CRP) and melanoma inhibiting activity protein (MIA) have also shown diagnostic and prognostic potential in melanoma patients, but with limitations in routine clinical use due to significant intra- and inter-patient variation, limitations in specificity and sensitivity of current technology and lack of consistency in blood sampling, storage and processing [6].